Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimization of levodopa therapy.

R Pfeiffer1

  • 1Section of Neurology, University of Nebraska Medical School, Omaha 68198-2045.

Neurology
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Starting levodopa therapy for Parkinson's disease requires careful dosing to avoid toxicity. Treatment adjustments and non-pharmacologic strategies are essential for managing symptoms and improving patient function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experimental Investigations on Protective Inoculation of Men against Typhus Abdominalis.

The Indian medical gazette·2017
Same author

Risk of myeloid neoplasms after solid organ transplantation.

Leukemia·2014
Same author

Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease.

Parkinsonism & related disorders·2014
Same author

Chemical analysis for ochratoxin poisoning.

Mycotoxin research·2013
Same author

Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation.

Oncogenesis·2013
Same author

A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.

Neurology·2012
Same journal

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026
Same journal

Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

Neurology·2026
Same journal

Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

Neurology·2026
Same journal

Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

Neurology·2026
Same journal

Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

Neurology·2026
Same journal

At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

Neurology·2026
See all related articles

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Levodopa is a primary treatment for Parkinson's disease.
  • Optimal dosing and management strategies are crucial for efficacy and safety.

Purpose of the Study:

  • To outline best practices for initiating and managing levodopa therapy in Parkinson's disease.
  • To discuss adjunctive treatments, adverse effects, and non-pharmacologic interventions.

Main Methods:

  • Review of current therapeutic guidelines for levodopa.
  • Discussion of common adverse effects and management strategies.
  • Emphasis on individualized treatment approaches.

Main Results:

  • No single starting dose for levodopa is universally correct; 25/100 or controlled-release formulas are common starting points.

Related Experiment Videos

  • Titration should avoid "normality" to prevent toxicity.
  • Adjunctive medications and reassessment of therapy are standard.
  • Management of adverse effects like GI disorders, hypotension, psychosis, and sleep disturbances is critical.
  • Non-pharmacologic interventions including exercise, physical therapy, and support groups are vital.

    • Conclusions:

    • Individualized treatment plans are essential for levodopa therapy in Parkinson's disease.
    • Careful monitoring for adverse effects and timely therapeutic adjustments are necessary.
    • A multimodal approach combining pharmacologic and non-pharmacologic strategies optimizes patient outcomes.